期刊： LANCET NEUROLOGY, 2021; 20 (6)
Background Post-stroke cognitive impairment (PSCI) occurs in approximately half of people in the first year after stroke. Infarct location is a potent......
期刊： LANCET NEUROLOGY, 2021; 20 (8)
Patients with isolated rapid-eye-movement sleep behaviour disorder (RBD) are commonly regarded as being in the early stages of a progressive neurodege......
期刊： LANCET NEUROLOGY, 2021; 20 (4)
China has approximately 10 million people with epilepsy. There is a vast epilepsy treatment gap in China, mainly driven by deficiencies in health-care......
期刊： LANCET NEUROLOGY, 2021; 20 (2)
Background The genetic basis of variation in the progression of primary tauopathies has not been determined. We aimed to identify genetic determinants......
期刊： LANCET NEUROLOGY, 2021; 20 (4)
Background Balancing the risks of recurrent ischaemic stroke and intracranial haemorrhage is important for patients treated with antithrombotic therap......
期刊： LANCET NEUROLOGY, 2020; 19 (1)
China has the largest population of patients with dementia in the world, imposing a heavy burden on the public and health care systems. More than 100 ......
期刊： LANCET NEUROLOGY, 2020; 19 (2)
Background Previous randomised trials have shown an overwhelming benefit of mechanical thrombectomy for treating patients with stroke caused by large ......
期刊： LANCET NEUROLOGY, 2020; 19 (3)
A growing awareness about brain health and Alzheimer's disease in the general population is leading to an increasing number of cognitively unimpaired ......
期刊： LANCET NEUROLOGY, 2020; 19 (5)
Background Azathioprine is used as a first-line treatment to prevent relapses of neuromyelitis optica spectrum disorder (NMOSD). Tocilizumab has been ......
